Regeneron Pharmaceuticals, Inc. (REGN), Bayer HealthCare (BAY) Say Eye Drug Meets Mid-stage Goal  
2/18/2010 7:55:47 AM

Bookmark and Share

Reuters -- Regeneron Pharmaceuticals and Bayer HealthCare, a U.S. unit of Germany's Bayer, said their experimental drug to treat retinal swelling brought on by diabetes, met its primary goal in a mid-stage study.